Rendering

Component: (Network and Table)
Network
31101 - Disclosure - EARNINGS PER SHARE (Tables)
(http://aralez.com/role/DisclosureEarningsPerShareTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
EARNINGS PER SHAREPeriod [Axis]
2016-01-01 - 2016-12-31
EARNINGS PER SHARE
 
Schedule of basic and diluted loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Year Ended December 31,

 

 

    

2016

    

2015

    

2014

 

 

 

 

(in thousands, except share and per share data)

 

Net (loss) income, basic

 

$

(102,978)

 

$

(37,783)

 

$

19,675

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrants liability

 

 

(4,744)

 

 

 —

 

 

 —

 

Net loss, diluted

 

$

(107,722)

 

$

(37,783)

 

$

19,675

 

 

 

 

 

 

 

 

 

 

 

 

Shares used in calculating basic net loss per common share

 

 

61,830,967

 

 

32,589,795

 

 

31,359,867

 

Effect of dilutive securities:

 

 

 

 

 

 

 

 

 

 

Effect of dilutive stock options

 

 

 —

 

 

 —

 

 

1,450,720

 

Warrants to purchase common shares - liability-classified

 

 

52,049

 

 

 —

 

 

 —

 

Shares used in calculating diluted net loss per common share

 

 

61,883,016

 

 

32,589,795

 

 

32,810,587

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per common share, basic

 

$

(1.67)

 

$

(1.16)

 

$

0.63

 

Net (loss) income per common share, diluted

 

$

(1.74)

 

$

(1.16)

 

$

0.60

 

 

  
Potential common shares excluded from the calculation of diluted net loss per share

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Year Ended December 31,

 

 

    

2016

    

2015

    

2014

  

 

 

 

 

 

 

 

 

Options to purchase common shares, RSUs and PSUs

 

7,388,888

 

 —

 

 —

 

Warrants to purchase common shares - equity-classified

 

92,223

 

 —

 

 —

 

2022 Notes convertible into common shares

 

8,190,534

 

 —

 

 —

 

 

  
Summary of warrants outstanding and exercisable

 

 

 

 

 

 

 

 

No. of Warrants

 

Weighted-Average

Quarterly period of expiration

    

Outstanding

    

Exercise Price

Q2 2017

 

46,497

 

$

4.71

Q1 2018

 

599,278

 

 

4.12

Q3 2018

 

15,815

 

 

3.78

Q4 2019

 

107,670

 

 

4.81

Q3 2020

 

109,968

 

 

4.09

Q1 2021

 

50,521

 

 

2.91

 

 

929,749

 

$

4.16